The optimal number of lymph nodes examined in stage II colorectal cancer and its impact of on outcomes

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Choi, Hok K ^a   Law, Wai L ^a   Poon, Jensen T C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; SURVIVAL RATE; ADJUVANT CHEMOTHERAPY; BIOPSY; COLON RESECTION; COLORECTAL TUMOR; KAPLAN MEIER METHOD; LYMPH NODE; LYMPHADENECTOMY; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77953126479     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-267     Document Type: Article

References (23)

1. Wolmark N, Rockette H, Fisher B, Wickerham DL, Redmond C, Fisher ER, Jones J, Mamounas EP, Ore L, Petrelli NJ. The benefits of leucovorin - modulated fluorouracil as postoperative therapy for primary colon cancers: results from the National Surgical Adjuvant Breast and Bowel Project. J Clin Oncol 1993, 11:1879-87.
2. Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J, Miedema B, Ota D, Sargent D. National Cancer Institute Expert Panel. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001, 93:583-96. 10.1093/jnci/93.8.583, 11309435.
3. Scott KWM, Grace RH. Detection of lymph node metastases in colorectal cancinoma before and after fat clearance. Br J Surg 1989, 76:1165-7. 10.1002/bjs.1800761118, 2688803.
4. Fielding LP, Arsenault PA, Chapuis PH, Dent O, Gathright B, Hardcastle JD, Hermanek P, Jass JR, Newland RC. Clinicopathologic staging for colorectal cancer: an international documentation system (IDS) and an international comprehensive anatomical terminology (ICAT). J Gastroenterol Hepatol 1991, 6:325-44. 10.1111/j.1440-1746.1991.tb00867.x, 1912440.
5. Hernanz F, Revuelta S, Redondo C, Madrazo C, Castillo J, Gómez-Fleitas M. Colorectal adenocarcnoma: quality of the assessment of lymph node metastases. Dis Colon Rectum 1994, 37:373-7. 10.1007/BF02053600, 8168417.
6. Goldstein NS, Sanford W, Coffey M, Layfield LJ. Lymph node recovery from colorectal resection specimens removed for adenocarcinoma: trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 1996, 106:209-16.
7. Maurel J, Launoy G, Grosclaude P, Gignoux M, Arveux P, Mathieu-Daudé H, Raverdy N, Faivre J. Lymph node harvest reporting in patients with carcinoma of the large bowel: a French population-based study. Cancer 1998, 82:1482-6. 10.1002/(SICI)1097-0142(19980415)82:8<1482::AID-CNCR8>3.0.CO;2-B, 9554524.
8. Tepper JE, O'Connell MJ, Niedzwiecki D, Hollis D, Compton C, Benson AB, Cummings B, Gunderson L, Macdonald JS, Mayer RJ. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 2001, 19:157-63.
9. Cianchi F, Palomba A, Boddi V, Messerini L, Pucciani F, Perigli G, Bechi P, Cortesini C. Lymph node recovery from colorectal tumour specimens: Recommendation for a minimum number of lymph nodes to be examined. World J Surg 2002, 26:384-9. 10.1007/s00268-001-0236-8, 11865379.
10. Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 2003, 10:65-71. 10.1245/ASO.2003.03.058, 12513963.
11. Tsai HL, Lu CY, Hsieh JS, Wu DC, Jan CM, Chai CY, Chu KS, Chan HM, Wang JY. The prognostic significance of total lymph node harvest in patients with T2-4N0M0 colorectal cancer. J Gastrointest Surg 2007, 11:660-5. 10.1007/s11605-007-0119-x, 17468927.
12. Vather R, Sammour T, Zargar-Shoshtari K, Metcalf P, Connolly A, Hill A. Lymph node examination as a predictor of long term outcome in Dukes B colon cancer. Int J Colorectal Dis 2009, 24:283-8. 10.1007/s00384-008-0540-y, 18716784.
13. International Union Against Cancer (UICC): TNM classification of malignant tumors. 2002, New York: Wiley, Sobin LH, Wittekind CH, 6.
14. Newland RC, Chapuis PH, Smythe EJ. The prognostic value of substaging colorectal carcinoma: a prospective study of 1117 cases with standardized pathology. Cancer 1987, 60:852-7. 10.1002/1097-0142(19870815)60:4<852::AID-CNCR2820600422>3.0.CO;2-5, 3594403.
15. Wolmark N, Fisher B, Wieand HS. The prognostic value of the modification of the Dukes C class of colorectal cancer: an analysis of the NSABP trial. Ann Surg 1986, 139:846-52.
16. Brown HG, Luckasevic TM, Medich DS, Celebrezze JP, Jones SM. Efficacy of manual dissection of lymph nodes in colon cancer resections. Mod Pathol 2004, 17:402-6. 10.1038/modpathol.3800071, 14976530.
17. Herrera-Ornelas L, Justiniano J, Castillo N, Petrelli NJ, Stulc JP, Mittelman A. Metastases in small lymph nodes from colon cancer. Arch Surg 1987, 122:1253-6.
18. Wright FC, Law CH, Last LD, Ritacco R, Kumar D, Hsieh E, Khalifa M, Smith AJ. Barriers to optimal assessment of lymph nodes in colorectal cancer specimens. Am J Clin Pathol 2004, 121:663-70. 10.1309/17VKM33BFXF9T8WD, 15151206.
19. Compton C, Fielding L, Burgart L, Conley B, Cooper HS, Hamilton SR, Hammond ME, Henson DE, Hutter RV, Nagle RB, Nielsen ML, Sargent DJ, Taylor CR, Welton M, Willett C. Prognostic factors in colorectal cancer: College of American Pathologists consensus statement 1999. Arch Pathol Lab Med 2000, 124:979-94.
20. Hsu CW, Lin CH, Wang HT, Ou WC, King TM. Factors that influence 12 or more harbested lymph nodes in early-stage colorectal cancer. World J Surg 2009, 33:333-9. 10.1007/s00268-008-9850-z, 19082656.
21. Horzic M, Kopljar M. Minimal number of lymph nodes that need to be examined for adequate staging of colorectal cancer - Factors influencing lymph node harvest. Hepatogastroenterology 2005, 52:86-9.
22. Bembenek AE, Rosenberg R, Wagle E, Gretschel S, Sendler A, Siewert JR, Nährig J, Witzigmann H, Hauss J, Knorr C, Dimmler A, Gröne J, Buhr HJ, Haier J, Herbst H, Tepel J, Siphos B, Kleespies A, Koenigsrainer A, Stoecklein NH, Horstmann O, Grützmann R, Imdahl A, Svoboda D, Wittekind C, Schneider W, Wernecke KD, Schlag PM. Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg 2007, 245:858-63. 10.1097/01.sla.0000250428.46656.7e, 1876954, 17522509.
23. Quadros CA, Lopes A, Araujo I, Fregnani JH, Fahel F. Upstaging benefits and accuracy of sentinel lymph node mapping in colorectal adenocarcinoma nodal staging. J Surg Oncol 2008, 98:324-30. 10.1002/jso.21112, 18618578.